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ABSTRACT 
Objective: To develop an accurate, simple, precise and specific stability indicating RP-HPLC method for estimation of dimethyl fumarate in bulk and 
capsules. 
Methods: An Inertsil ODS (150x4.6 mm, 5µ) column and a mobile phase containing acetonitrile: potassium dihydrogen phosphate buffer pH 6.8 
(50:50% v/v) was used for this study. The flow rate was maintained at 1.0 ml/min; column temperature was fixed at 35 °C and UV detection was 
carried out at 210 nm. The forced degradation studies were performed and method was validated with as per ICH guidelines. 
Results: The retention time of dimethyl fumarate was found to be 3.3±0.02 min. The value of correlation coefficient between peak area and concentration 
was found to be 0.9993. The mean percent recovery of dimethyl fumarate in capsules was found in the range of 99.65 to 101.64%. The results of forced 
degradation studies indicated that the drug was found to be stable in basic, oxidative and thermal conditions while degraded in acidic conditions. 
Conclusion: It can be conducted from results that the developed HPLC method is simple, accurate, precise and specific. Results of stress testing 
study revealed that the method is stability indicating. Thus, this method can be used for routine analysis of dimethyl fumarate capsules and check 
their stability.  
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Dimethyl fumarate is an anti-inflammatory drug, which is chemically 
trans-Butenedioic acid dimethyl ester [1]. The US FDA approved 
Tecfidera capsules (containing 240 mg of dimethyl fumarate) on 
March 27, 2013. This drug is indicated for the treatment of a patient 
with relapsing forms of multiple sclerosis [2]. Dimethyl fumarate is not 
an official drug in any Pharmacopoeia. Literature survey revealed that 
some methods have been reported for the determination of dimethyl 
fumarate by HPLC [3-6] and hyphenated techniques such as LC-MS [7], 
either alone or in combination. However, there is no stability 
indicating HPLC assay method was reported yet for estimation of 
dimethyl fumarate in capsules. This paper presents a simple stability 
indicating RP-HPLC assay method for estimation of dimethyl fumarate 
in bulk and capsules that can be used in stability testing. 
 
 
Fig. 1: Chemical structure of dimethyl fumarate 
 
MATERIALS AND METHODS 
Chemicals and reagents 
Dimethyl Fumarate API was procured from Enaltec Research Centre, 
Ambernath, India as a gift sample. Capsules (containing 240 mg of 
dimethyl fumarate) were obtained in a house in Enaltec Research Centre. 
Methanol, Acetonitrile was obtained from Rankem Pvt. Ltd, Mumbai and 
Perchloric acid was obtained from Merck Specialties Pvt. Ltd, Mumbai. 
Instruments 
The method was performed on Shimadzu LC-2010C HT HPLC system 
with automatic injection facility and UV-Visible detection system. 
Analytical Balance Mettler Toledo XS205 and Column Symmetry 
Shield Inertsil ODS (150 x 4.6 mm, 5µ) were used for this study. 
Preparation of standard stock solution 
100 mg of dimethyl fumarate was accurately weighed and transferred 
into a 100 ml volumetric flask. This drug was dissolved with 30 ml of 
methanol and sonicated for 15 min. Then this solution was diluted up 
to the mark with a diluent (Acetonitrile: buffer PH 6.8 50:50% v/v) 
this solution was further diluted 10 times with the same diluent. 
Assay of capsules 
The content of twenty capsules was weighed and an average weight 
of a capsule was calculated. An accurately weighed amount of 
powder equivalent to 100 mg of drug was transferred to a 100 ml 
volumetric flask and 30 ml of methanol was added to it. Then the 
mixture was sonicated for 15 min and diluted up to mark with the 
diluent. This solution was further diluted to obtain about 100 μg/ml 
solutions with the same diluent and filtered through 0.45µ nylon 
membrane syringe filter before injection. This procedure was 
repeated in triplicate. The results of the assay of capsules are shown 
in table 2. 
Validation of the method 
The developed chromatographic method was validated for linearity, 
range, accuracy, precision, robustness and specificity parameters, as 
per ICH guidelines [8]. 
Linearity and range 
Working standard solutions were injected under the optimized 
chromatographic conditions and peak areas were calculated at 210 
nm. A calibration curve was plotted between areas against 
corresponding concentrations of the drug. Linear regression data for 
calibration curve was shown in fig. 3. The range of solution has been 
decided according to Karl Pearson’s correlation coefficient. 
Precision 
Repeatability study was carried out with six replicates and 
intermediate precision studies were carried out with three 
concentrations of dimethyl fumarate with three replicates. The 
values of % relative standard deviation (% RSD) of precision study 
are shown in table 3. 
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The accuracy of the method was determined by calculating 
percent recovery of the drug by standard addition method. 
Percent recovery of dimethyl fumarate was determined at three 
different levels 50, 100 and 150% of the target concentration in 
triplicate. The results of accuracy study are shown in table 4. 
Robustness 
Robustness of the optimized method was studied by changing flow 
rate (±0.2 ml/min), change in wavelength (±2 nm) and change in 
mobile phase composition (±5%) during analysis. The sample was 
injected in triplicate for every condition and cumulative % RSD was 
calculated for each condition is shown in table 5. 
Specificity 
Blank (diluent), standard, sample and identification solutions 
(spiked with a fumaric acid and monomethyl fumarate impurities) 
were injected to HPLC. The results (retention time, purity angle and 
purity threshold) obtained by this study is summarized in table 6. 
The chromatograms obtained by this study are presented in fig. 4(a), 
(b) and (c).  
Forced degradation studies 
To evaluate stability, dimethyl fumarate was subjected to force 
degradation conditions (acid, base, neutral hydrolysis and oxidation 
as well as heat) as per international conference on harmonization 
(ICH) guidelines [9-12]. 
No treatment sample was prepared similarly as assay procedure for 
capsules. The chromatogram of no treatment sample is presented in 
fig. 5(a). 
Acid hydrolysis 
An accurately weighed amount of capsule’s powder equivalent to 
100 mg of dimethyl fumarate was transferred to a 100 ml 
volumetric flask. Then 5 ml of 0.1N HCl was added and refluxed at 
80 °C for 1 h [13]. This solution was neutralized by adding 5 ml of 
0.1 N NaOH. Methanol (30 ml) was added to this mixture and 
sonicated for 15 min.  
Then volume was made up to the mark with diluent. The resultant 
solution was further diluted, filtered and analyzed using HPLC. The 
chromatogram obtained by acid hydrolysis is given in fig. 5(b). 
Alkaline hydrolysis 
An accurately weighed amount of capsule’s powder equivalent to 
100 mg of dimethyl fumarate was transferred to a 100 ml 
volumetric flask. Then 5 ml of 0.1N NaOH was added and 
refluxed at 80 °C for 1 h [14]. This solution was neutralized by 
adding 5 ml of 0.1 N HCl. Methanol (30 ml) was added to this 
mixture and sonicated for 15 min. Then volume makeup, further 
dilution, filtration and analysis was done similar to acid 
hydrolysis. The chromatogram obtained by alkaline hydrolysis is 
given in fig. 5(c). 
Oxidative degradation 
An accurately weighed amount of capsule’s powder equivalent to 
100 mg of dimethyl fumarate was transferred to a 100 ml volumetric 
flask. Then 5 ml of 3% H2O2 was added and refluxed at 80 °C for 1 h. 
Methanol (30 ml) was added to this mixture and sonicated for 15 
min. Then volume makeup, further dilution, filtration and analysis 
were done similar to acid hydrolysis. The chromatogram obtained 
by oxidative degradation is given in fig. 5(d). 
Thermal degradation 
An accurately weighed amount of powder equivalent to 100 mg of 
drug was taken and kept in oven for 1 h 105 °C. Sample was 
transferred to 100 ml volumetric flask and 30 ml of methanol was 
added to it. Then the mixture was sonicated for 15 min. the sample 
was allowed to cool at room temperature. Then volume make up, 
further dilution, filtration and analysis was done similar to acid 
hydrolysis. The chromatogram obtained by thermal degradation is 
given in fig. 5(e). 
Stability of analytical solutions 
The standard and sample solutions were kept at bench top and in 
stability chamber at 15 °C for 46 h and injected from time to time on 
to the HPLC. The data obtained are summarized in table 7. 
Filter compatibility study 
Unfiltered and filtered standard solutions (by PVDF, Nylon, and 
PTFE) were injected to HPLC system. Sample solutions were 
centrifuged at 5000 rpm for 10 min, filtered similarly as standard 
solutions and injected to the HPLC system. The data obtained by this 
study is summarized in table 8. 
RESULTS AND DISCUSSION 
Optimization of chromatographic conditions 
UV spectrum of dimethyl fumarate showed the maximum 
absorbance of the drug was found at 210 nm. Hence, 210 nm 
wavelength was selected for UV detection. Initially, various 
chromatographic conditions were tried in order to obtain better 
separation characteristics, by changing the composition of different 
mobile phases. Finally, mobile phase consists of acetonitrile: 
potassium dihydrogen phosphate buffer pH 6.8 (50:50% v/v) was 
selected at a flow rate of 1.0 ml/min and UV detection (210 nm). The 
value of retention time of drug was found to be 3.46 min, indicated 
that the method is rapid. The chromatogram of dimethyl fumarate is 
shown in fig. 2. The optimized chromatographic conditions and 
system suitability parameters are mentioned in table 1. 
Assay of capsules formulation 
The value of mean % drug in the capsules was found to be 100.1 % 
(table 2), which was within acceptance criteria. 
Precision 
The method is precise and the % RSD values were within an 
acceptable limit. 
 
Table 1: Optimized chromatographic conditions and system suitability parameters 
Parameters Details 
Mobile phase Acetonitrile: Potassium dihydrogen phosphate buffer pH 6.8 (50:50% v/v) 
Column GL Science, Inertsil ODS, 150 x 4.6 mm, 5µ. 
Flow rate 1.0 ml/min 
Detection 210 nm 
Injection volume 5 μl 
Run time 7 min 
Retention time 3.3+0.02 min 
Diluent Acetonitrile: (Potassium dihydrogen phosphate) buffer Ph 6.8 (50:50% v/v) 
Tailing factor 1.25 
Theoretical plates 5857 
 
Trivedi et al. 




Fig. 2: Chromatogram of dimethyl fumarate 
 
Table 2: Results of assay of dimethyl fumarate 
S. No. Sample solution concentration (μg/ml) Area Amount of drug estimated mean±%RSD* 
1 100 8549821  
2 100 8569754 100.1±0.12 
3 100 8567736  
*The value is represented as a mean±%RSD of 3 observations. 
 
Table 3: Repeatability and intermediate precision for dimethyl fumarate 
Precision Concentration of drug (μg/ml) Mean area±SD* % RSD 
Repeatability (n=6) 100 8705641±68889 0.82 
Intra-day (n=3) 75 6377573.3±9957 1.57 
100 8329129.3±7385 0.88 
125 108269176±3335 0.30 
Inter-day (n=3) 75 6377573.3±15357 0.24 
100 8368268.3±168167 2.00 
125 10979590.3±592188 0.5 
*Each value is represented as a mean±SD of n observations. SD: standard deviation, %RSD: Percent relative standard deviation. 
 
Accuracy 
The values of percent recovery of the developed method (table 4) 
were found in acceptance criteria. Results of accuracy studies of the 
method were found satisfactory as the average mean % recovery±RSD 
was 100.5±0.56 %. Therefore, this method is accurate. 
Linearity and range 
The value of correlation coefficient for dimethyl fumarate (fig. 3) 
demonstrated the good relationship between peak areas and 
concentrations. Therefore, the developed method was found to be 
linear in the concentration range of 25-150 μg/ml. 
 
Table 4: Recovery study for dimethyl fumarate 
Level % Amount taken (μg/ml) % recovery* Mean % recovery±RSD 
50  99.87 100.5±0.63 
15 102.00 
 98.28 
100  99.40 99.65±0.36 
20 100.07 
 99.48 
150  102.30 101.64±0.70 
25 101.17 
 101.46 
*Percent recovery was in triplicate, % recovery: Percent recovery, %RSD: Percent relative standard deviation. 
 
 
Fig. 3: Calibration curve of dimethyl fumarate 
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The value of % RSD was found to be within acceptance criteria 
which showed the reliability of the method. 
Specificity 
The results of specificity study are shown in fig. 4 (a), (b) and (c). 
The obtained chromatograms showed that there no interfering peak 
was observed of blank, sample and standard solution at the 
retention time of dimethyl fumarate. Purity angle was observed that 
less than purity threshold for all peak observed. The value of 
retention time of dimethyl fumarate for standard solution and 
sample was same, however, the retention time of expected 
components was observed at different values. All these parameters 
indicated the specificity of the method. 
Forced degradation studies 
Chromatograms obtained under different stress conditions like 
acidic, alkaline hydrolysis, oxidative, thermal degradation are 
presented in fig no. 5(a), 5(b), 5(c), 5(d) and 5(e). 
 
Table 5: Robustness study for dimethyl fumarate 
Parameters % RSD 
A: Change in flow rate (±0.2 ml/min)  
0.8 ml/min 0.13% 
1 ml/min 0.11% 
1.2 ml/min 0.19% 
B: Change in Mobile Phase (±5%)  
Buffer: ACN (55:45) v/v 0.28% 
Buffer: ACN (50:50) v/v 0.12% 
Buffer: ACN (45:55) v/v 0.07% 
C: Change in wavelength (±2 nm)  
208 nm 0.34% 
210 nm 0.12% 
212 nm 0.22% 
 
Table 6: Specificity study for dimethyl fumarate 
 Component Retention time (min) Purity angle Purity threshold 
Blank Dimethyl fumarate No --- --- 
Dimethyl fumarate standard Dimethyl fumarate 3.436 0.190 0.268 
Identification solution Fumaric acid   Fumaric acid 1.637 6.709 14.58 
Identification solution monomethyl Fumarate Monomethyl fumarate 2.078 0.841 1.156 
Sample 240 mg Dimethyl fumarate 3.432 0.199 0.273 
Spiked sample 240 mg Dimethyl fumarate 3.436 0.121 10.084 
Fumaric acid 1.645 10.520 12.774 
Monomethyl fumarate 2.079 2.993 13.818 
 
 
Fig. 4 (a): Chromatogram of blank solution 
 
 
Fig. 4 (b): Chromatogram of standard solution 
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Fig. 5: Typically degradation chromatograms of dimethyl fumarate; (a) in control sample; (b) in 0.1 N HCl at 80 °C after 1 h; (c) in 0.1 N 
NaOH at 80 °C after 1 h; (d) in 3% H2O2 at 80 °C after 1 h; (e) in thermal degradation at 105 °C after 1 h 
 
The first chromatogram obtained by control sample [fig. 4(a)] was 
used for degradation of dimethyl fumarate but there was no 
degradation. Second chromatogram obtained by acid hydrolysis [fig. 
4(b)] suggested that 14.7% degradation of the drug was found, when 
refluxed at 80 °C for 1 h in 0.1 N HCl. The major degradation product 
formed was at 3.467 min retention time. This study indicates that 
dimethyl fumarate was not stable to acid hydrolysis. Third 
chromatogram obtained by alkaline hydrolysis [fig. 4(c)] indicated 
that dimethyl fumarate was stable to alkaline hydrolysis when 
refluxed at 80 °C for 1 h in 0.1 N NaOH. The Value of % degradation 
was found to be 0.3% and major degradation products appeared at 
3.46 min retention time. Fourth chromatogram obtained by 
oxidative degradation [fig. 4(d)] suggested that 1.18% degradation 
was observed when refluxed with 3% H2O2 at 80 °C for 1 h. The 
major degradation products appeared at 3.44 min retention time. 
Fifth chromatogram obtained by thermal degradation [fig. 4(e)] 
suggested that 0.1% degradation was observed indicating that 
dimethyl fumarate is stable when refluxed at 105 °C for 1 h. The 
major degradation product was obtained at 3.45 min retention time.  
Stability of analytical solution 
The stability data obtained is summarized in table 7. The values of % RSD 
of standard and sample solution were found within acceptance criteria. 
Filter compatibility study 
Percent RSD of unfiltered and filtered standard solutions, as well as 
sample solutions (table 8), is found within the limit. Hence, these 
filters are compatible. 
 
Table 7: Stability of analytical solutions 
 Initial Bench top(46 h) 15 °C(46 h) 
Standard solution % RSD 0.11 1.08 0.96 
Sample solution % RSD 0.14 0.67 1.24 
 
Table 8: Filter compatibility study of standard and sample 
Filter Standard (%RSD) Sample (%RSD) 
Unfiltered 0.56 Centrifuge (0.44) 
0.45µ Nylon Filter 1.02 0.40 
0.45µ PVDF Filter 0.80 0.39 
0.45µ PTFE Filter 0.27 1.65 




The present study represents the first report for stability-indicating 
HPLC assay for estimation of dimethyl fumarate in bulk and 
capsules. The method was successfully validated as per ICH 
guidelines. Results of stress testing study revealed that the method 
is stability indicating. It can be concluded from the results that the 
developed method is simple, rapid, accurate, specific and precise. 
Thus, this method can be used for routine analysis of dimethyl 
fumarate API and to check the stability of capsules dosage forms. 
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